PortfoliosLab logoPortfoliosLab logo
^NDX vs. NOVO-B.CO
Performance
Return for Risk
Drawdowns
Volatility

Performance

^NDX vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NASDAQ 100 Index (^NDX) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

^NDX is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, ^NDX achieves a 17.37% return, which is significantly higher than NOVO-B.CO's -10.15% return. Over the past 10 years, ^NDX has outperformed NOVO-B.CO with an annualized return of 20.95%, while NOVO-B.CO has yielded a comparatively lower 17.63% annualized return.


^NDX

1D
0.64%
1M
0.19%
YTD
17.37%
6M
17.62%
1Y
37.01%
3Y*
25.76%
5Y*
16.18%
10Y*
20.95%

NOVO-B.CO

1D
1.53%
1M
-5.28%
YTD
-10.15%
6M
-8.95%
1Y
-41.84%
3Y*
6.83%
5Y*
19.41%
10Y*
17.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

^NDX vs. NOVO-B.CO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
^NDX
NASDAQ 100 Index
17.37%20.17%24.88%53.81%-32.97%26.63%47.58%37.96%-1.04%31.52%
NOVO-B.CO
Novo Nordisk A/S
-10.15%-39.54%-15.04%214.95%23.90%65.39%27.16%32.88%-10.64%58.82%

Correlation

The correlation between ^NDX and NOVO-B.CO is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Sep 7, 2007

0.22

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

^NDX vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

^NDX
^NDX Risk / Return Rank: 7979
Overall Rank
^NDX Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
^NDX Sortino Ratio Rank: 7979
Sortino Ratio Rank
^NDX Omega Ratio Rank: 8181
Omega Ratio Rank
^NDX Calmar Ratio Rank: 7878
Calmar Ratio Rank
^NDX Martin Ratio Rank: 7676
Martin Ratio Rank

NOVO-B.CO
NOVO-B.CO Risk / Return Rank: 1313
Overall Rank
NOVO-B.CO Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NOVO-B.CO Sortino Ratio Rank: 1414
Sortino Ratio Rank
NOVO-B.CO Omega Ratio Rank: 1212
Omega Ratio Rank
NOVO-B.CO Calmar Ratio Rank: 1313
Calmar Ratio Rank
NOVO-B.CO Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

^NDX vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NASDAQ 100 Index (^NDX) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


^NDXNOVO-B.CODifference
Sharpe ratioReturn per unit of total volatility

+2.82

Sortino ratioReturn per unit of downside risk

+3.57

Omega ratioGain probability vs. loss probability

1.36

0.88

+0.48

Calmar ratioReturn relative to maximum drawdown

2.92

-0.79

+3.71

Martin ratioReturn relative to average drawdown

10.85

-1.17

+12.02

^NDX vs. NOVO-B.CO - Sharpe Ratio Comparison

The current ^NDX Sharpe Ratio is 2.05, which is higher than the NOVO-B.CO Sharpe Ratio of -0.77. The chart below compares the historical Sharpe Ratios of ^NDX and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

^NDX vs. NOVO-B.CO - Drawdown Comparison

The maximum ^NDX drawdown since its inception was -82.90%, which is greater than NOVO-B.CO's maximum drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for ^NDX and NOVO-B.CO.


Loading charts...

Drawdown Indicators


^NDXNOVO-B.CODifference

Max Drawdown

Largest peak-to-trough decline

-82.90%

-74.86%

-8.04%

Max Drawdown (1Y)

Largest decline over 1 year

-12.12%

-54.48%

+42.36%

Max Drawdown (3Y)

Largest decline over 3 years

-22.93%

-74.86%

+51.93%

Max Drawdown (5Y)

Largest decline over 5 years

-35.56%

-74.86%

+39.30%

Max Drawdown (10Y)

Largest decline over 10 years

-35.56%

-74.86%

+39.30%

Current Drawdown

Current decline from peak

-3.34%

-67.88%

+64.54%

Average Drawdown

Average peak-to-trough decline

-24.61%

-12.38%

-12.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.26%

36.72%

-33.46%

Volatility

^NDX vs. NOVO-B.CO - Volatility Comparison

The current volatility for NASDAQ 100 Index (^NDX) is 7.51%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 12.08%. This indicates that ^NDX experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


^NDXNOVO-B.CODifference

Volatility (1M)

Calculated over the trailing 1-month period

7.51%

12.08%

-4.57%

Volatility (6M)

Calculated over the trailing 6-month period

13.84%

40.71%

-26.87%

Volatility (1Y)

Calculated over the trailing 1-year period

17.29%

55.70%

-38.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.76%

58.93%

-36.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.61%

45.48%

-22.87%

Frequently Asked Questions


^NDX and NOVO-B.CO have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ^NDX and NOVO-B.CO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer